Nanobac Pharmaceuticals, Incorporated
NNBP
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Net Income | -6.58M | -6.71M | -6.66M | -7.34M | -4.97M |
| Total Depreciation and Amortization | 460.30K | 463.90K | 467.20K | 469.70K | 541.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.45M | 3.40M | 3.17M | 3.73M | 1.51M |
| Change in Net Operating Assets | 1.75M | 1.37M | 1.11M | 784.80K | 339.00K |
| Cash from Operations | -910.90K | -1.47M | -1.92M | -2.36M | -2.58M |
| Capital Expenditure | -1.50K | -3.10K | -10.30K | -10.40K | -12.70K |
| Sale of Property, Plant, and Equipment | 0.00 | -6.50K | -3.30K | -3.30K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.10K | 50.40K | 50.40K | 50.40K | -2.70K |
| Cash from Investing | 48.60K | 40.70K | 36.70K | 36.60K | -15.50K |
| Total Debt Issued | 910.90K | 1.39M | 1.75M | 1.77M | 2.74M |
| Total Debt Repaid | -- | 0.00 | 0.00 | -14.70K | -53.70K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 910.90K | 1.39M | 1.75M | 1.76M | 2.69M |
| Foreign Exchange rate Adjustments | -84.20K | -71.20K | -52.20K | -60.20K | -58.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.60K | -110.10K | -185.90K | -619.80K | 30.50K |